Shilajit/Fulvic Acid / uPA Cancer Research Results

FulvicA, Shilajit/Fulvic Acid: Click to Expand ⟱
Features:
Fulvic acid is a naturally occurring compound found in soil, compost, and marine sediments. It is a complex mixture of many organic acids and has been studied for its antioxidant, anti-inflammatory, and immune-modulating properties.
Shilajit is a complex mineral–organic exudate found in mountainous regions (e.g., Himalayas). It contains fulvic acids, humic substances, dibenzo-α-pyrones (DBPs), trace minerals, and other low-molecular-weight compounds. Most standardized extracts are characterized by fulvic acid content (often 15–60%).

AD:
-Fulvic acid may help inhibit tau fibril formatio
-Antioxidant activity
-Anti-inflammatory effects

Cancer:
-Fulvic acid’s role in reducing drug resistance and improving drug absorption has been suggested
-Synergistic effects with chemotherapy

Fulvic Acid database results: Note how it is antioxidant for normal cells, but may produce ROS in cancer cells. (explains synergistic effect with chemo)
LeafSource Fulvic Acid note how they use Fulvic Acid to improve bioavailability of berberine.

Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Mitochondrial function / electron transport support Bioenergetic modulation (context-dependent) ATP production support ↑ (reported) P, R Mitochondrial optimization Dibenzo-α-pyrones and fulvic acids are reported to support mitochondrial respiration in non-cancer models.
2 Nrf2 / antioxidant response Redox tone modulation (model-dependent) Nrf2 ↑; antioxidant enzymes ↑ R, G Redox buffering Commonly described as antioxidant; tumor-direction effects are not well established.
3 NF-κB inflammatory signaling NF-κB ↓ (reported; limited cancer data) Inflammation tone ↓ R, G Anti-inflammatory modulation Anti-inflammatory effects are better documented than direct tumor cytotoxicity.
4 ROS modulation ROS ↓ or stabilized (context-dependent) Oxidative stress ↓ P, R, G Antioxidant effect Acts primarily as redox stabilizer rather than ROS generator.
5 AMPK / metabolic stress pathways Metabolic modulation (limited direct tumor evidence) Energy homeostasis support ↑ R, G Metabolic adaptation Some reports suggest improved metabolic efficiency; not a primary oncologic mechanism.
6 Cell-cycle / apoptosis Apoptosis ↑ (reported in limited preclinical studies) ↔ G Conditional cytotoxicity Data are sparse and largely cell-line based; not a strong, consistent cytotoxic signature.
7 Immune modulation Immune tone modulation (context-dependent) Immune support ↑ R, G Adaptogenic effect Traditional use emphasizes immune and vitality support rather than direct anticancer activity.
8 Metal chelation / mineral transport Trace mineral transport effects (uncertain tumor relevance) Mineral absorption modulation P Biochemical modulation Fulvic acid has chelation properties; relevance to oncology unclear.
9 Quality / contamination risk Variable depending on preparation Heavy metal exposure risk if unrefined — Safety constraint Crude shilajit may contain heavy metals; purified standardized extracts preferred.
10 Bioavailability variability Systemic exposure varies by extraction/purification — — Translation constraint Composition varies widely; standardization typically based on fulvic acid content.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (rapid mitochondrial/redox interactions)
  • R: 30 min–3 hr (acute signaling and metabolic shifts)
  • G: >3 hr (gene-regulatory adaptation and phenotype outcomes)
uPA, Urokinase plasminogen activator: Click to Expand ⟱
Source:
Type:
uPA (urokinase plasminogen activator) is a serine protease that plays a crucial role in the conversion of plasminogen to plasmin, an enzyme responsible for degrading various components of the extracellular matrix (ECM). This activity is central to processes such as tissue remodeling, cell migration, and angiogenesis. In the context of cancer, uPA facilitates tumor invasion and metastasis by promoting ECM degradation, while its interaction with its receptor (uPAR) and inhibitors (such as PAI-1) forms a regulatory axis that is frequently dysregulated in malignancies.

Patients with higher pretreatment serum uPA (≥1 ng/ml) had significantly shorter OS.

Elevated uPA expression has been observed in a broad range of cancers, including breast, colorectal, lung, and prostate cancers. These high levels are often indicative of increased proteolytic activity within the tumor microenvironment.
Tumors with aggressive behavior often exhibit upregulation of uPA, along with its receptor uPAR. This upregulation enhances plasmin generation and leads to an environment conducive to invasion and metastasis.

Elevated uPA levels in tumor tissues have been strongly associated with poor clinical outcomes. High uPA expression is correlated with increased risk of metastasis, higher likelihood of recurrence, and reduced overall survival in several cancer types.
Scientific Papers found: Click to Expand⟱
4023- FulvicA,    Shilajit (Mumio) Elicits Apoptosis and Suppresses Cell Migration in Oral Cancer Cells through Targeting Urokinase-type Plasminogen Activator and Its Receptor and Chemokine Signaling Pathways
- in-vitro, Oral, NA
tumCV↓, selectivity↑, Apoptosis↑, uPA↓, TumCMig↓, Dose↝, CXCc↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Cell Death ⓘ

Apoptosis↑, 1,  

Transcription & Epigenetics ⓘ

tumCV↓, 1,  

Migration ⓘ

TumCMig↓, 1,   uPA↓, 1,  

Immune & Inflammatory Signaling ⓘ

CXCc↓, 1,  

Drug Metabolism & Resistance ⓘ

Dose↝, 1,   selectivity↑, 1,  
Total Targets: 7

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: uPA, Urokinase plasminogen activator
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:358  Target#:428  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page